October 12, 2017 / 8:47 AM / a year ago

CVC and Tethys Invest in exclusive talks for Sebia majority stake

LONDON, Oct 12 (Reuters) - Buyout fund CVC Capital Partners' strategic opportunities platform and the L'Oreal family's Tethys Invest have entered exclusive talks to acquire a majority stake in France's Sebia, the companies said on Thursday.

Founded in 1967, Sebia provides medical equipment and technology used for in-vitro diagnostic testing. It was acquired by Montagu Private Equity and Astorg Partners in 2014 for an undisclosed amount that sources put at around $1.4 billion.

Tethys Invest was set up by Françoise Bettencourt Meyers and Jean-Pierre Meyers and is a subsidiary of the main shareholder of French cosmetics giant L'Oreal.

Reporting by Dasha Afanasieva; editing by Jason Neely

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below